Clinical trial · Interventional
Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer
Feasibility Study on the Possibility of Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer
NCT03703557CI-TRIAL-00049092KDOG2completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To ascertain the possibilities to isolate the breast cancer olfactive signature.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Odour sampling | Diagnostic Test | — | UNRESOLVED |
| Sorbstar® | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Sorbstar®
- description
- Odour sampling: Rub hands with Sorbstar® before and post-surgery
- interventionNames
- Diagnostic Test: Sorbstar®
- type
- EXPERIMENTAL
- label
- Dog detection
- description
- Odour sampling: Sleep over a night with a compress on the affected breast before and after surgery
- interventionNames
- Diagnostic Test: Odour sampling
Primary outcomes (1)
- measure
- Ascertain breast cancer olfactive signature (Isolation of volatile Organic Compounds to breast cancer by a sensitive technique with an odor-sensing polymer (Sorbstar®)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient received in surgery consultation for an invasive non metastatic breast cancer treated by breast-conserving surgery with axillary or sentinel node dissection 2. Of-Age female patient (over 18 years old) 3. Life expectancy \> to 1 year at the inclusion 4. Performance status: 0 or 1 or 2 5. Patient benefiting from the social security 6. Signature informed consent of the study Exclusion Criteria: 1. Neoplasia in progress or neoplasia history of cancer other than breast to be treated. 2. Wound presence on breasts 3. Male subjects 4. Specified metastatic breast cancer 5. Concomitant medication taken one month before the surgical act (antibiotics, corticoids, anti-diabetics) 6. Persons under guardianship or deprived of liberty 7. Impossibility to submit to the medical monitoring expected by the study for geographical, social or psychological reasons.
References
Publications (0)
Data not yet available
No reference posted for this study.